NORTHERN TRUST CORP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,519,457
+6.3%
518,586
+3.7%
0.00%
Q2 2023$1,430,023
-4.7%
500,008
+2.9%
0.00%
Q1 2023$1,501,236
+39.5%
485,837
-4.7%
0.00%
Q4 2022$1,075,894
+39.9%
509,902
+116.4%
0.00%
Q3 2022$769,000
-1.0%
235,642
-2.8%
0.00%
Q2 2022$777,000
-9.9%
242,389
+98.5%
0.00%
Q1 2022$862,000
-4.3%
122,089
-1.8%
0.00%
Q4 2021$901,000124,3760.00%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
LUMINUS MANAGEMENT LLC 400,000$1,144,0000.34%
Endowment Wealth Management, Inc. 97,518$319,4810.29%
Imprint Wealth LLC 95,646$326,1530.21%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 38,000$108,6800.11%
Prescott General Partners LLC 568,246$1,625,1840.10%
HAMILTON LANE ADVISORS LLC 52,693$1510.07%
United Asset Strategies, Inc. 183,960$526,1260.07%
GSA CAPITAL PARTNERS LLP 148,585$4250.04%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 450,000$1,282,5000.03%
Shay Capital LLC 50,236$143,6750.02%
View complete list of HUMACYTE INC shareholders